{
  "kind": "framework",
  "value": "3-pillar-framework",
  "collectionKey": "slides:framework:3-pillar-framework:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 4,
  "page": 1,
  "pageSize": 24,
  "pageCount": 1,
  "rows": [
    {
      "docId": "019de075-a698-70b1-b3ba-29e176396a9c",
      "docSlug": "63ec8e773c9b43e7b033b64167026114",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 52 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a 3-pillar framework to explain the platform, followed by a product-specific breakdown.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "The slide explicitly labels '3 Pillars' as the structural basis for the platform.",
      "slideHref": "/slides/019de075-a698-70b1-b3ba-29e176396a9c/41",
      "deckHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c",
      "deckAnchorHref": "/decks/019de075-a698-70b1-b3ba-29e176396a9c#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
      "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-10-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a '3 Pillars' framework to explain the platform foundation, followed by a product-specific breakdown.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "The slide explicitly labels the left section as '3 Pillars'.",
      "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/44",
      "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
      "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 57,
          "from": 37,
          "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
          "arcName": "The Sparkline",
          "arcSlug": "sparkline",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
          "position": 7,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5",
      "docSlug": "225408061c3ed04b028031d27cf2467f",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides",
      "authorId": "immix-biopharma",
      "authorName": "ImmixBio",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 61,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a 3-pillar framework to explain the platform, then maps these to specific drug candidates with detailed mechanism-of-action descriptions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "The slide explicitly labels the left column as '3 Pillars'.",
      "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/61",
      "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5",
      "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-61",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 62,
          "from": 35,
          "beatId": "676eee44-bd9e-41af-b9af-35da1fc6b1d6",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "The document outlines the market opportunity, competitive landscape, and future plans for NXC-201 and other pipeline assets.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-ab6f-74fc-ae2c-88fa7eed31fd",
      "docSlug": "9e6f9592721adb102aeba3d640e068ca",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 64 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 63,
      "slideType": "other",
      "function": "present_solution",
      "notes": "The slide uses a 3-pillar framework to categorize the platform's foundation, leading to specific product applications.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "The slide explicitly labels the left column as '3 Pillars'.",
      "slideHref": "/slides/019de076-ab6f-74fc-ae2c-88fa7eed31fd/63",
      "deckHref": "/decks/019de076-ab6f-74fc-ae2c-88fa7eed31fd",
      "deckAnchorHref": "/decks/019de076-ab6f-74fc-ae2c-88fa7eed31fd#slide-63",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 64,
          "from": 37,
          "beatId": "55323ebe-ee93-4119-be72-15ce337e4875",
          "arcName": "The Consultant's Gambit",
          "arcSlug": "consultants-gambit",
          "beatName": "Impact & Next Steps",
          "beatSlug": "consultants-gambit-impact-next-steps",
          "evidence": "Slides 37-64 discuss the market opportunity, clinical development plan, and upcoming catalysts",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}